HPR176 Reimbursement of Antineoplastic and Immunomodulating Agents in Turkey: Comparison With Approvals of the FDA Between 2010-2021
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1305
https://www.valueinhealthjournal.com/article/S1098-3015(22)03510-0/fulltext
Title :
HPR176 Reimbursement of Antineoplastic and Immunomodulating Agents in Turkey: Comparison With Approvals of the FDA Between 2010-2021
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03510-0&doi=10.1016/j.jval.2022.09.1305
First page :
Section Title :
Open access? :
No
Section Order :
10853